PediaMetrix Receives $2 Million NIH Grant to Expand Pediatric AI Diagnostic Tools
PediaMetrix has secured a $2 million NIH Commercialization Readiness Program grant to advance its FDA-cleared SoftSpot mobile app for pediatric skull screening and develop new AI tools for early detection of ear and dental deformities in children.
PediaMetrix, Inc., creator of the FDA-cleared SoftSpot mobile app for pediatric skull-shape screening, has been awarded a $2 million grant through the National Institutes of Health Commercialization Readiness Program to accelerate commercialization of its pediatric health solutions. The funding will support the advancement of SoftSpot's 2D and 3D imaging capabilities and the development of next-generation AI tools for early detection of pediatric ear and dental deformities.
The NIH's Commercialization Readiness Program serves a later-stage mission designed to bridge the gap between development and full-scale commercialization for promising biomedical technologies. This grant will enable PediaMetrix to prepare SoftSpot and associated AI tools for broader clinical and commercial adoption, positioning the company to expand its impact on pediatric healthcare.
SoftSpot pioneers early detection of cranial shape abnormalities at the point of care, having empowered pediatricians and parents to scan infants' heads quickly and efficiently. With this CRP award, the newly expanded SoftSpot Total Care Solution will include both refined 2D and enhanced 3D scanning capabilities, delivering richer diagnostic insights that could improve early intervention outcomes for infants.
Looking beyond cranial analysis, PediaMetrix is developing complementary AI solutions including EarSpot for early ear deformity screening and upcoming tools for detecting dental and other pediatric abnormalities. The company's expansion into multiple pediatric diagnostic areas represents a significant advancement in accessible, technology-driven healthcare for children.
The grant funding underscores the growing importance of AI-powered diagnostic tools in pediatric medicine and the critical role of public-private partnerships in bringing innovative healthcare solutions to market. As PediaMetrix continues to grow its research and development teams, this investment positions the company to address multiple critical pediatric health needs through computer vision and artificial intelligence technologies.